<p>Review of Adjuvant Therapies in Renal Cell Carcinoma: Evidence to Date</p>
Eliana MC Tacconi(Medtronic (Italy)), Andrew Protheroe(University of Oxford)
Cited by 30
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial
|The Lancet Oncology|2014|194
A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours
|British Journal of Cancer|2008|82
Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response
|Cancer Research|2021|49
Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression and drug response
|bioRxiv (Cold Spring Harbor Laboratory)|2019|10